Insider Shareholders with Direct Ownership of Trevi Therapeutics, Inc. (TRVI)
This section provides a comprehensive overview of the insiders with direct ownership of Trevi Therapeutics, Inc. (TRVI). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Trevi Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
New Enterprise Associates 16, L.P.
> 10% Shareholder |
4,483,430 | 0 | 10,421,428 $28.3 Million | 2 |
Apr 11, 2022
Added 20.16%
|
|
Thomas Sciascia
Chief Scientific Officer |
59,354 | 53,368 | 214,433 $583,257 | 2 |
May 29, 2024
Reduced 19.93%
|
|
Jennifer L Good
President & CEO |
29,615 | 29,615 | 213,313 $580,211 | 4 |
May 20, 2024
Reduced 10.5%
|
|
Lisa Delfini
Chief Financial Officer |
61,875 | 18,593 | 53,279 $144,918 | 20 |
May 22, 2024
Reduced 7.55%
|
|
Farrell Simon
Chief Commercial Officer |
25,000 | 0 | 45,650 $124,168 | 2 |
Jun 20, 2023
Added 12.04%
|